PARIS: Cyclists who dope themselves with EPO may not gain any performance advantage even though they are putting their health at risk, scientists said on Thursday. In a review of the evidence, a team ...
No, that's not an endorsement or a suggestion -- but it's the interesting implication of a new study from the University of Zurich (abstract here; press release here). EPO is (in)famous as a ...
HUNTINGTON BEACH, California — A phase 1 trial of erythropoietin (Epo) found that the drug, given to neonates with hypoxic-ischemic encephalopathy (HIE) along with hypothermia treatment, was well ...
In a review of the evidence, a team of European researchers on Thursday scoffed at the notion that erythropoietin (EPO) gives cyclists an edge. And they pointed out that the drug has many perils for ...
Cyclists who dope themselves with EPO may not gain any performance advantage even though they are putting their health at risk, scientists said on Thursday. In a review of the evidence, a team of ...
Using a small interfering RNA (siRNA) drug to stimulate natural EPO production by the liver can help avoid the risks. Using a small interfering RNA (siRNA) drug to stimulate natural EPO production by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results